Holdings of Pictet - Biotech
ISIN LU0090689299 · LU0190161025 · LU0190162189 · LU0255977372 · LU0255977455 · LU0255977539
Pictet Asset Management (Europe) S.A. · 67 declared positions · as of Sep 30, 2025
Fund report · Net assets 1.5B $ · Ten largest lines: 33.0 % of net assets · Fees at most 1.2 to 2.9 % depending on the share class (3) · Compare with another fund · Report an error
Positions
| Rank | Company | Currency | Shares | Value | Weight |
|---|---|---|---|---|---|
| 1 | UNITED THERAPEUTICS United States | USD | 154,907 | 65.5M $ | 4.40 % |
| 2 | INSMED United States | USD | 443,064 | 63.1M $ | 4.25 % |
| 3 | ARGEN-X ADR-SPONS.- Netherlands | USD | 81,163 | 58.9M $ | 3.96 % |
| 4 | REGENERON PHARMACEUTICALS United States | USD | 85,398 | 48.5M $ | 3.26 % |
| 5 | ALNYLAM PHARMACEUTICALS United States | USD | 104,151 | 47M $ | 3.16 % |
| 6 | NEUROCRINE BIOSCIENCES United States | USD | 334,855 | 46.9M $ | 3.15 % |
| 7 | MADRIGAL PHARMACEUTICALS United States | USD | 98,606 | 43.9M $ | 2.95 % |
| 8 | BIOGEN United States | USD | 289,313 | 40.4M $ | 2.71 % |
| 9 | GILEAD SCIENCES United States | USD | 342,985 | 38.9M $ | 2.61 % |
| 10 | MERUS Netherlands | USD | 411,283 | 38.6M $ | 2.59 % |
| 11 | PTC THERAPEUTICS United States | USD | 627,686 | 38.4M $ | 2.58 % |
| 12 | CRINETICS PHARMACEUTICALS United States | USD | 833,467 | 35.2M $ | 2.37 % |
| 13 | RHYTHM PHARMACEUTICALS United States | USD | 344,479 | 35M $ | 2.35 % |
| 14 | TG THERAPEUTICS United States | USD | 938,506 | 34.5M $ | 2.32 % |
| 15 | IONIS PHARMACEUTICALS United States | USD | 503,383 | 32.4M $ | 2.18 % |
| 16 | REVOLUTION MEDICINES United States | USD | 686,878 | 31.7M $ | 2.13 % |
| 17 | PROTAGONIST THERAPEUTICS United States | USD | 472,690 | 31M $ | 2.09 % |
| 18 | AVIDITY BIOSCIENCES United States | USD | 714,506 | 30.8M $ | 2.07 % |
| 19 | CYTOKINETICS United States | USD | 556,896 | 30.7M $ | 2.06 % |
| 20 | CG ONCOLOGY United States | USD | 760,671 | 29.7M $ | 2.00 % |
| 21 | SCHOLAR ROCK HOLDING United States | USD | 762,357 | 28.8M $ | 1.94 % |
| 22 | ABIVAX France | EUR | 332,857 | 28.3M $ | 1.90 % |
| 23 | VERA THERAPEUTICS 'A' United States | USD | 872,632 | 25.9M $ | 1.74 % |
| 24 | BRIDGEBIO PHARMA United States | USD | 491,194 | 25.4M $ | 1.71 % |
| 25 | AXSOME THERAPEUTICS United States | USD | 204,287 | 24.2M $ | 1.63 % |
| 26 | AKERO THERAPEUTICS United States | USD | 487,095 | 23.2M $ | 1.56 % |
| 27 | MIRUM PHARMACEUTICALS -S- United States | USD | 303,545 | 22.4M $ | 1.51 % |
| 28 | XENON PHARMACEUTICALS Canada | USD | 559,188 | 22.1M $ | 1.48 % |
| 29 | PICTET - SOVEREIGN SHORT-TERM MONEY MARKET USD - Z Luxembourg | USD | 169,627 | 22M $ | 1.48 % |
| 30 | MINERALYS THERAPEUTICS United States | USD | 540,778 | 21.4M $ | 1.44 % |
| 31 | AMICUS THERAPEUTICS United States | USD | 2,632,465 | 20.9M $ | 1.41 % |
| 32 | KINIKSA PHARMA United States | USD | 524,937 | 20.3M $ | 1.37 % |
| 33 | NEWAMSTERDAM PHARMACEUTICALS COMPANY Netherlands | USD | 728,482 | 20.2M $ | 1.36 % |
| 34 | VAXCYTE United States | USD | 572,767 | 20M $ | 1.34 % |
| 35 | SOLENO THERAP United States | USD | 291,024 | 19.7M $ | 1.33 % |
| 36 | KRYSTAL BIOTECH United States | USD | 109,978 | 19.3M $ | 1.30 % |
| 37 | ARCELLX United States | USD | 235,405 | 19.2M $ | 1.29 % |
| 38 | NUVALENT 'A' United States | USD | 212,985 | 18.1M $ | 1.22 % |
| 39 | ENLIVEN THERP RG United States | USD | 868,238 | 17.5M $ | 1.18 % |
| 40 | CELLDEX THERAPEUTICS United States | USD | 673,474 | 17.4M $ | 1.17 % |
| 41 | ULTRAGENYX PHARMACEUTICAL United States | USD | 565,629 | 17.2M $ | 1.16 % |
| 42 | VIKING THERAPEUTICS United States | USD | 669,174 | 17.1M $ | 1.15 % |
| 43 | BIOMARIN PHARMACEUTICALS United States | USD | 308,076 | 16.7M $ | 1.13 % |
| 44 | IDEAYA BIOSCIENCES United States | USD | 575,764 | 15.8M $ | 1.06 % |
| 45 | INCYTE United States | USD | 182,752 | 15.4M $ | 1.04 % |
| 46 | ACADIA PHARMACEUTICALS United States | USD | 622,788 | 13.3M $ | 0.89 % |
| 47 | VIRIDIAN THERAPEUTICS United States | USD | 590,689 | 12.6M $ | 0.85 % |
| 48 | AMGEN United States | USD | 43,153 | 12M $ | 0.81 % |
| 49 | NURIX THERAPEUTICS United States | USD | 1,143,402 | 10.6M $ | 0.72 % |
| 50 | SUMMIT THERAPEUTICS United States | USD | 494,055 | 10.5M $ | 0.70 % |
| 51 | VERTEX PHARMACEUTICALS United States | USD | 24,260 | 9.6M $ | 0.65 % |
| 52 | SPYRE THERAPEUTICS United States | USD | 587,003 | 9.5M $ | 0.64 % |
| 53 | DAY ONE BIOPHARMACEUTICALS United States | USD | 1,336,982 | 9.4M $ | 0.63 % |
| 54 | ZEALAND PHARMA Denmark | DKK | 127,415 | 9.2M $ | 0.62 % |
| 55 | OLEMA PHARMACEUTICALS United States | USD | 947,398 | 9.1M $ | 0.61 % |
| 56 | KYMERA THERAPEUTICS United States | USD | 147,012 | 8.6M $ | 0.58 % |
| 57 | ALKERMES Ireland | USD | 286,288 | 8.5M $ | 0.57 % |
| 58 | JANUX THERAPEUTICS United States | USD | 329,556 | 7.9M $ | 0.53 % |
| 59 | IMMUNOVANT United States | USD | 367,487 | 5.9M $ | 0.39 % |
| 60 | TERNS PHARMACEUTICALS United States | USD | 623,226 | 4.8M $ | 0.33 % |
| 61 | CENTESSA PHARMACEUTICALS -ADR SPONS.- United Kingdom | USD | 190,613 | 4.6M $ | 0.31 % |
| 62 | PEPGEN United States | USD | 435,551 | 2.1M $ | 0.14 % |
| 63 | MOONLAKE IMMUNOTHERAPEUTICS 'A' Cayman Islands | USD | 70,452 | 446.7K $ | 0.03 % |
| 64 | INTARCIA THERAPEUTICS PFD AA United States | USD | 40,219 | 0 $ | 0.00 % |
| 65 | INTARCIA THERAPEUTICS PFD BB1 United States | USD | 62,497 | 0 $ | 0.00 % |
| 66 | INTARCIA THERAPEUTICS PFD BB2 United States | USD | 387,583 | 0 $ | 0.00 % |
| 67 | INTARCIA THERAPEUTICS PFD CC United States | USD | 25,924 | 0 $ | 0.00 % |
Source: report published by Pictet - Biotech.
Country breakdown
- United States 85.7 %
- Netherlands 7.9 %
- France 1.9 %
- Canada 1.5 %
- Luxembourg 1.5 %
- Denmark 0.6 %
- Ireland 0.6 %
- United Kingdom 0.3 %
Countries from the fund report. Weights in % of net assets.
Currency breakdown
- USD 97.5 %
- EUR 1.9 %
- DKK 0.6 %
The quoted currency of each line, as declared.
Cite this page
Titelia. "Holdings of Pictet - Biotech". https://titelia.com/en/funds/pictet-biotech